Prognostic impact of tumor size on patients with neuroblastoma in a SEER‐based study (Englisch)
Freier Zugriff
- Neue Suche nach: Wang, Jin‐Xia
- Neue Suche nach: Cao, Zi‐Yang
- Neue Suche nach: Wang, Chun‐Xia
- Neue Suche nach: Zhang, Hong‐Yang
- Neue Suche nach: Fan, Fei‐Long
- Neue Suche nach: Zhang, Jun
- Neue Suche nach: He, Xiao‐Yan
- Neue Suche nach: Liu, Nan‐Jing
- Neue Suche nach: Liu, Jiang‐Bin
- Neue Suche nach: Zou, Lin
- Neue Suche nach: Wang, Jin‐Xia
- Neue Suche nach: Cao, Zi‐Yang
- Neue Suche nach: Wang, Chun‐Xia
- Neue Suche nach: Zhang, Hong‐Yang
- Neue Suche nach: Fan, Fei‐Long
- Neue Suche nach: Zhang, Jun
- Neue Suche nach: He, Xiao‐Yan
- Neue Suche nach: Liu, Nan‐Jing
- Neue Suche nach: Liu, Jiang‐Bin
- Neue Suche nach: Zou, Lin
In:
Cancer Medicine
;
11
, 14
;
2779-2789
;
2022
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Prognostic impact of tumor size on patients with neuroblastoma in a SEER‐based study
-
Beteiligte:Wang, Jin‐Xia ( Autor:in ) / Cao, Zi‐Yang ( Autor:in ) / Wang, Chun‐Xia ( Autor:in ) / Zhang, Hong‐Yang ( Autor:in ) / Fan, Fei‐Long ( Autor:in ) / Zhang, Jun ( Autor:in ) / He, Xiao‐Yan ( Autor:in ) / Liu, Nan‐Jing ( Autor:in ) / Liu, Jiang‐Bin ( Autor:in ) / Zou, Lin ( Autor:in )
-
Erschienen in:Cancer Medicine ; 11, 14 ; 2779-2789
-
Verlag:
-
Erscheinungsdatum:01.07.2022
-
Format / Umfang:11 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 11, Ausgabe 14
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 2727
-
Issue Information| 2022
- 2729
-
Diagnosing gastrointestinal stromal tumors: The utility of fine‐needle aspiration cytology versus biopsyZhang, Yifan / Renberg, Sara / Papakonstantinou, Andri / Haglund de Flon, Felix et al. | 2022
- 2735
-
Characteristics of anal canal cancer in JapanYamada, Kazutaka / Saiki, Yasumitsu / Komori, Koji / Shiomi, Akio / Ueno, Masashi / Ito, Masaaki / Hida, Koya / Yamamoto, Seiichiro / Shiozawa, Manabu / Ishihara, Soichiro et al. | 2022
- 2744
-
Comparison of sampling methods for next generation sequencing for patients with lung cancerKunimasa, Kei / Matsumoto, Shingo / Nishino, Kazumi / Honma, Keiichiro / Maeda, Noboru / Kuhara, Hanako / Tamiya, Motohiro / Inoue, Takako / Kawamura, Takahisa / Kimura, Toru et al. | 2022
- 2755
-
Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgeryYang, Yilan / Zhao, Xu / Wang, Xuanyi / Jin, Kairui / Luo, Jurui / Yang, Zhaozhi / Mei, Xin / Ma, Jinli / Shao, Zhimin / Zhang, Zhen et al. | 2022
- 2767
-
Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER‐targeted therapy in HER2 amplification‐positive and HER2 mutation‐positive amplification‐negative patientsLiu, Binliang / Yi, Zongbi / Guan, Yanfang / Ouyang, Quchang / Li, Chunxiao / Guan, Xiuwen / Lv, Dan / Li, Lixi / Zhai, Jingtong / Qian, Haili et al. | 2022
- 2779
-
Prognostic impact of tumor size on patients with neuroblastoma in a SEER‐based studyWang, Jin‐Xia / Cao, Zi‐Yang / Wang, Chun‐Xia / Zhang, Hong‐Yang / Fan, Fei‐Long / Zhang, Jun / He, Xiao‐Yan / Liu, Nan‐Jing / Liu, Jiang‐Bin / Zou, Lin et al. | 2022
- 2790
-
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non‐small cell lung cancerSolomon, Benjamin / Callejo, Ana / Bar, Jair / Berchem, Guy / Bazhenova, Lyudmila / Saintigny, Pierre / Wunder, Fanny / Raynaud, Jacques / Girard, Nicolas / Lee, J. Jack et al. | 2022
- 2801
-
Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathyZhang, Xindi / Trendowski, Matthew R. / Wilkinson, Emma / Shahbazi, Mohammad / Dinh, Paul C. / Shuey, Megan M. / Feldman, Darren R. / Hamilton, Robert J. / Vaughn, David J. / Fung, Chunkit et al. | 2022
- 2817
-
Relapse in patients with limited‐stage ocular adnexal lymphoma treated by chemoimmunotherapy: Extended follow‐up of a phase 2 studyKim, Sung‐Yong / Lee, Won‐Sik / Oh, Sung Yong / Yang, Deok‐Hwan / Kim, Hyo Jung / Park, Seong Kyu / Yang, Jae Wook / Yang, Suk‐Woo / Cho, Seok‐Goo et al. | 2022
- 2824
-
Ursolic acid silences CYP19A1/aromatase to suppress gastric cancer growthMa, Wen‐Lung / Chang, Ning / Yu, Yingchun / Su, Yu‐Ting / Chen, Guan‐Yu / Cheng, Wei‐Chung / Wu, Yang‐Chang / Li, Ching‐Chia / Chang, Wei‐Chun / Yang, Juan‐Cheng et al. | 2022
- 2836
-
The prognostic effect of residual tumor for advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy or primary debulking surgeryYang, Shi‐Ping / Chen, Jian‐Xian / Xu, Jing‐Ying / Lei, Jian / Wu, San‐Gang / Zhou, Juan et al. | 2022
- 2846
-
Adjuvant radiotherapy shows benefit in selected stage I uterine sarcoma: A risk scoring system based on a population analysisHuang, Yun‐xia / Lin, Yan‐zong / Li, Yi‐min / Chu, Ke‐xin / Zhou, Yu‐fei / Lin, Li‐mei / Zhou, Rui / Zhang, Zong‐kai / Lin, Qin et al. | 2022
- 2855
-
Serum tumor markers level and their predictive values for solid and micropapillary components in lung adenocarcinomaLi, Zhihua / Wu, Weibing / Pan, Xianglong / Li, Fang / Zhu, Quan / He, Zhicheng / Chen, Liang et al. | 2022
- 2865
-
Tumor marker response to SARS‐CoV‐2 infection among patients with cancerGunn, Alexander H. / Tashie, Carolyn / Wolf, Steven / Troy, Jesse D. / Zafar, Yousuf et al. | 2022